GPN Vaccines Ltd is pleased to announce that dose escalation has been approved and dosing of the second cohort has commenced in its Phase 1 clinical trial of Gamma-PN vaccine in older adults.
AGIS' C5ISR combined Air and Ground C5ISR System fulfills the need for an integrated, All-Domain, C5ISR combined arms capability that can seamlessly operate either as an independent Air and Ground system or can function as an integrated Air and Ground C5ISR System capable of simultaneously performing both Air and Ground functions.
Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, highlighted a newly presented study demonstrating the clinical value of its portable Viscoelastic Coagulation Monitor (VCM) in a safety analysis of Anti-Xa and the VCM.
GenieUs Genomics (“GenieUs”) is excited to provide advanced genomic analysis for Neurizon Therapeutics Limited’s (“Neurizon”; ASX:NUZ; ASX:NUZOA) Phase 1 clinical trial of monepantel, now known as NUZ-001, marking an important step in understanding the genetic landscape of ALS patients.
“From Fear to Peace” is more than just a self-help guide; it’s a practical toolkit designed to help readers navigate life’s toughest challenges with clarity and calm.
MOIN, a leading cross-border remittance service provider, has successfully collaborated with Visa to address a long-standing challenge in cross-border payments: the inability to seamlessly transmit detailed non-financial data alongside financial transactions.
Recent data reveals a staggering 83% increase in climate-related disasters, escalating from 3,656 incidents between 1980 and 1999 to 6,681 from 2000 to 2019 (Source: Climate Centre).
